Cediranib in patients with alveolar soft-part sarcoma (CASPS) : a double-blind, placebo-controlled, randomised, phase 2 trial - Judson, Ian (The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust) ; Morden, James P. (The Institute of Cancer Research) ; Kilburn, Lucy (The Institute of Cancer Research) ; Leahy, Michael (The Christie NHS Foundation Trust) ; Benson, Charlotte (The Royal Marsden NHS Foundation Trust) ; Bhadri, Vivek (Chris O'Brien Lifehouse) ; Campbell-Hewson, Quentin (Newcastle upon Tyne Hospitals NHS Foundation Trust) ; Cubedo, Ricardo (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Dangoor, Adam (University Hospitals Bristol NHS Foundation Trust) ; Fox, Lisa (The Institute of Cancer Research) ; Hennig, Ivo (Nottingham University Hospitals NHS Trust (Regne Unit)) ; Jarman, Katy (The Institute of Cancer Research) ; Joubert, Warren (Princess Alexandra Hospital) ; Kernaghan, Sarah (The Institute of Cancer Research) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; McNeil, Catriona (Chris O'Brien Lifehouse) ; Seddon, Beatrice (University College London Hospitals NHS Foundation Trust) ; Snowdon, Claire (The Institute of Cancer Research) ; Tattersall, Martin (Chris O'Brien Lifehouse) ; Toms, Christy (The Institute of Cancer Research) ; Martinez Trufero, Javier (Hospital Universitario Miguel Servet (Saragossa)) ; Bliss, Judith M. (The Institute of Cancer Research) ; Universitat Autònoma de Barcelona
 
Comments (0) | Reviews (0)
Start a discussion about any aspect of this document.

 Subscribe to this discussion. You will then receive all new comments by email.

Add comment


Once logged in, authorized users can also attach files.
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>